As obesity drug heavyweights Eli Lilly and Novo Nordisk gear up to release results for the third quarter, investors are ...

A MAJOR review has pitted three blockbuster fat jabs against each other – comparing weight lost and how long users were able ...

Amy Schumer revealed that she had tried medications like Ozempic and Wegovy before switching to Mounjaro, which she said ...

Somehow, it’s becoming even harder to get a GLP-1.

After a “horrible experience with Wegovy,” the comedian revealed in March that taking Mounjaro was working “really great” for her.

Amy Schumer's recent appearance in a red Valentino dress highlighted her comfort in her own skin after significant weight ...

Government hiring data is on hold during the shutdown, but earlier this month a survey by payroll company ADP showed a ...

Eli Lilly said on Wednesday it is partnering with Walmart to sell its weight-loss treatment Zepbound at the retailer's ...

The 44-year-old comedian — who has shed 'at least 40lbs' with help from GLP-1 weight loss drug Mounjaro — showed off her ...

Despite all that, there are some good reasons to consider buying into Novo Nordisk -- and the best is its low valuation, given its growth potential. The stock's recent price-to-earnings (P/E) ratio of ...

A few things happen when you get a corticosteroid injection at the dermatologist’s office. “We inject it into active inflamed ...